Crescent Capital BDC shareholders back 2026 votes
Crescent Capital BDC, Inc. held its 2026 annual stockholder meeting, where 36,969,285 common shares were entitled to vote as of March 18, 2026.
Rhea-AI Filing Summary
Crescent Capital BDC, Inc. held its 2026 annual stockholder meeting, where 36,969,285 common shares were entitled to vote as of March 18, 2026. Stockholders elected Susan Yun Lee and Michael S. Segal as Class II directors to terms running through the 2029 annual meeting. Lee received 17,107,252 votes for, 306,098 against, and 107,901 abstentions. Segal received 16,302,024 votes for, 1,113,132 against, and 106,095 abstentions. Shareholders also ratified Ernst & Young LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, with 26,529,354 votes for, 211,437 against, and 155,426 abstentions.
Positive
- None.
Negative
- None.
8-K Event Classification
Key Figures
Key Terms
Annual Meeting of Stockholders financial
Class II Directors financial
independent registered public accounting firm financial
broker non-votes financial
record date financial
FAQ
What did Crescent Capital BDC (CCAP) stockholders vote on at the 2026 annual meeting?
Who was elected as Class II directors of Crescent Capital BDC (CCAP) in 2026?
What were the vote totals for Crescent Capital BDC director Susan Yun Lee?
How did Crescent Capital BDC (CCAP) stockholders vote on Michael S. Segal as director?
Did Crescent Capital BDC (CCAP) ratify Ernst & Young as auditor for 2026?
AI-generated analysis. How Rhea-AI works. Not financial advice.